USP7-IN-6 is a potent ubiquitin specific protease 7 (USP7) inhibitor, extracted from patent WO2017212010A1, example 25, has an IC₅₀ of 6.8 nM^[1].

IC50: 6.8 nM (USP7)^[1]

USP7-IN-6 (example 25) shows cytotoxicity to Z138 tumour cells, with an IC₅₀ 1.1 nM^[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

729.89

C₄₁H₄₃N₇O₄S

2166586-47-4

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. András Kotschy, et al. New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them. WO2017212010A1.